• JIC Capital has signed an agreement to sell all JSR ordinary shares to Mitsui Chemicals and Development Bank of Japan.
• JSR will join Mitsui Chemicals' group, expanding its semiconductor materials portfolio and strengthening research capabilities.
• The sale follows JSR's June 2024 privatization, semiconductor materials investments and restructuring of its noncore life sciences business.
• For the fiscal year ended March 2026, JSR's core operating profit reached JPY 62.3 billion; net profit recovered to JPY 60.7 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JIC Capital Ltd published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.